[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"notifications-list":3,"$f1id4ddat695w4":5},{"data":4},[],{"data":6,"error":11},{"id":7,"documentId":8,"slug":9,"name":10,"medical_code":11,"short_description":12,"alternate_name":11,"disambiguating_description":11,"citations":13,"drugs":19,"specialties":33,"cover":11},1018,"urkk69x4ghp030gpfzb977fb","other-antineoplastic-agents","Other antineoplastic agents",null,"ANTINEOPLASTIC AGENTS > OTHER ANTINEOPLASTIC AGENTS > Other antineoplastic agents.",[14],{"source":15,"licence":16,"source_url":17,"retrieved_at":18},"WHO Collaborating Centre for Drug Statistics Methodology, ATCvet index","WHOCC ATCvet index, public reference","https:\u002F\u002Fatcddd.fhi.no\u002Fatcvet\u002Fatcvet_index\u002F?code=QL01XX91","2026-09-20",[20,26],{"id":21,"documentId":22,"slug":23,"name":23,"active_ingredient":11,"dosage_form":24,"administration_route":25},1898,"buvn3cdy0nmlbjssh1vyaa4t","masitinib","Film-coated tablet","Oral use",{"id":27,"documentId":28,"slug":29,"name":30,"active_ingredient":11,"dosage_form":31,"administration_route":32},1904,"k71zfhpoevf9088ue0xt6edb","tigilanol-tiglate","tigilanol tiglate","Solution for injection","Intratumoral use",[]]